Type 2 Diabetes

Drugs shown to increase risk of hypoglycemic and cardiovascular events.

Specific treatment recommendations outlined for this growing patient population.

GLP-1 treatment benefits patients on statins and with varying LDL levels.

Will perceived quality of life be affected by increasing antidiabetes medication burden on the patient?

New study shows diuresis, canagliflozin use nearly doubled risk of complications.

The beta-cell preserving properties of short courses of metformin and insulin glargine evaluated in ever-growing population of patients who have diabetes.

The best medication therapy for an individual with type 2 diabetes can depend on many factors, including ethnicity and multiple drug options.

Conflicting data exists about the association between coffee consumption and its effects on blood glucose, insulin concentration, and risk of type 2 diabetes.

Free potential treatment lowers blood sugars, helps with weight loss, drops blood pressure and cholesterol, and may add at least 10 years of quality of life.

First oral GLP-1 agonist undergoing Phase 3 trials shows significant benefits managing type 2 diabetes.